Retail News

FDA attaches warning to J&J COVID vaccine

The New York Times 07/13/2021

The Food and Drug Administration is warning consumers that Johnson & Johnson’s one-dose COVID-19 vaccine comes with an increased risk of developing Guillain-Barré syndrome, a rare neurological disorder that causes muscle weakness and occasional paralysis. Most people who contract Guillain-Barré recover from its severe symptoms.

MORE ON THIS STORY...

MORE RETAIL NEWS HEADLINES...

Discussions
Check out RetailWire's Engaging Online Discussions Featuring Our Exclusive Braintrust!